Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?

Skoči na glavni sadržaj

Reumatizam, Vol. 72 No. Supp 1, 2025.

Sažetak sa skupa

https://doi.org/10.33004/reumatizam-supp-72-1-82

Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?

Tanja Tatalović *
Felina Anić
Srđan Novak

* Dopisni autor.

Puni tekst: hrvatski pdf 651 Kb

str. 92-92

preuzimanja: 144

APA 6th Edition

Tatalović, T., Anić, F. i Novak, S. (2025). Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?. Reumatizam, 72 (Supp 1), 92-92. https://doi.org/10.33004/reumatizam-supp-72-1-82

MLA 8th Edition

Tatalović, Tanja, et al. "Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?." Reumatizam, vol. 72, br. Supp 1, 2025, str. 92-92. https://doi.org/10.33004/reumatizam-supp-72-1-82. Citirano 10.07.2026.

Chicago 17th Edition

Tatalović, Tanja, Felina Anić i Srđan Novak. "Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?." Reumatizam 72, br. Supp 1 (2025): 92-92. https://doi.org/10.33004/reumatizam-supp-72-1-82

Harvard

Tatalović, T., Anić, F., i Novak, S. (2025). 'Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?', Reumatizam, 72(Supp 1), str. 92-92. https://doi.org/10.33004/reumatizam-supp-72-1-82

Vancouver

Tatalović T, Anić F, Novak S. Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?. Reumatizam [Internet]. 2025 [pristupljeno 10.07.2026.];72(Supp 1):92-92. https://doi.org/10.33004/reumatizam-supp-72-1-82

IEEE

T. Tatalović, F. Anić i S. Novak, "Systemic sclerosis occurring in a patient with malignant melanoma treated with nivolumab – a paraneoplastic manifestation or a side effect of immunotherapy?", Reumatizam, vol.72, br. Supp 1, str. 92-92, 2025. [Online]. https://doi.org/10.33004/reumatizam-supp-72-1-82

Sažetak

Ključne riječi

Hrčak ID:

339974

URI

https://hrcak.srce.hr/339974

Datum izdavanja:

5.11.2025.

Podaci na drugim jezicima: hrvatski

Posjeta: 655 *